A prospective trial comparing FDG-PET/CT and CT to assess tumor response to cetuximab in patients with incurable squamous cell carcinoma of the head and neck

Computed tomography (CT), the standard method to assess tumor response to cetuximab in incurable squamous cell carcinoma of the head and neck (SCCHN), performs poorly as judged by the disparity between high disease control rate (46%) and short time to progression (TTP) (70 days). F-18 fluorodeoxyglu...

Descripción completa

Detalles Bibliográficos
Autores principales: Adkins, Douglas, Ley, Jessica, Dehdashti, Farrokh, Siegel, Marilyn J, Wildes, Tanya M, Michel, Loren, Trinkaus, Kathryn, Siegel, Barry A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2014
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4298375/
https://www.ncbi.nlm.nih.gov/pubmed/25081631
http://dx.doi.org/10.1002/cam4.294

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4298375/
https://www.ncbi.nlm.nih.gov/pubmed/25081631
http://dx.doi.org/10.1002/cam4.294

Ejemplares similares